Reshma Singh
15Patents
7h-index
35Co-inventors
62Inventor score
Filing activity: Sep 24, 2004 → Jul 11, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9777061B2 | Treatment of cancer using a CD33 chimeric antigen receptor | Chemistry; Metallurgy | 74 | Active |
| US10174095B2 | Nucleic acid encoding a humanized anti-BCMA chimeric antigen receptor | Chemistry; Metallurgy | 27 | Active |
| US7662396B2 | Compositions and methods for enhancing the immunogenicity of antigens | Chemistry; Metallurgy | 24 | Active |
| US7820180B2 | Listeria-based and LLO-based vaccines | Human Necessities | 23 | Expired |
| US7794729B2 | Methods and compositions for immunotherapy of cancer | Chemistry; Metallurgy | 20 | Active |
| US9463227B2 | Listeria-based adjuvants | Human Necessities | 16 | Active |
| US11084880B2 | Anti-BCMA chimeric antigen receptor | Chemistry; Metallurgy | 8 | Active |
| US10064898B2 | Listeria-based adjuvants | Emerging Cross-Sectional Technologies | 7 | Active |
| US10058599B2 | Suppressor cell function inhibition following Listeria vaccine treatment | Emerging Cross-Sectional Technologies | 6 | Active |
| US10568947B2 | Treatment of cancer using a CLL-1 chimeric antigen receptor | Chemistry; Metallurgy | 1 | Active |
| US11413340B2 | Mesothelin chimeric antigen receptor (CAR) and antibody against PD-L1 inhibitor for combined use in anticancer therapy | Human Necessities | 1 | Active |
| US10851166B2 | Treatment of cancer using a CD33 chimeric antigen receptor | Chemistry; Metallurgy | 1 | Active |
| US12214037B2 | Treatment of cancer using humanized anti-BCMA chimeric antigen receptor | Chemistry; Metallurgy | 0 | Active |
| US12186278B2 | Mesothelin chimeric antigen receptor (CAR) and antibody against PD-L1 inhibitor for combined use in anticancer therapy | Human Necessities | 0 | Active |
| US12338287B2 | Treatment of cancer using a CD33 chimeric antigen receptor | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.